Impact of the CAPTURE Chronic Obstructive Pulmonary Disease Screening Tool in U.S. Primary Care: A Cluster-Randomized Trial.

Fernando J Martinez¹, Barbara P Yawn², Daniela Angulo³, Camden Lopez³, Susan Murray³, David Mannino⁴, Stacey Anderson³, Rowena Dolor⁵, Nancy Elder⁶, Min Joo⁷, Irfan Khan⁸, Lyndee M Knox⁹, Catherine Meldrum¹⁰, Elizabeth Peters¹, Cathie Spino³, Hazel Tapp¹¹, Byron Thomashow¹², Linda Zittleman¹³, Randall Brown³, Barry Make¹⁴, MeiLan K Han¹⁰,

¹Division of Pulmonary Medicine, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, Massachusetts.

²Department of Family and Community Health, University of Minnesota, Minneapolis, Minnesota.

³School of Public Health and.

⁴Division of Pulmonary and Critical Care Medicine, University of Kentucky, Lexington, Kentucky.

⁵Division of General Internal Medicine, Duke University, Durham, North Carolina.

⁶Oregon Health and Science University, Portland, Oregon.

⁷Division of Pulmonary and Critical Care Medicine, University of Illinois, Chicago, Illinois.

⁸Circuit Clinical, Clarence Center, New York.

⁹L.A. Net Community Health Resource Network Collaboratory, Long Beach, California.

¹⁰Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, Michigan.

¹¹Department of Family Medicine, Atrium Health, Charlotte, North Carolina.

¹²Division of Pulmonary and Critical Care Medicine, Columbia University, New York, New York.

¹³Department of Family Medicine, University of Colorado, High Plains Research Network, Aurora, Colorado; and.

¹⁴Division of Pulmonary, Critical Care, and Sleep Medicine, National Jewish Health, Denver, Colorado.

PubMed PMC DOI PDF

Abstract

Rationale: The impact of screening for chronic obstructive pulmonary disease (COPD) on U.S. primary care clinician behavior and patient outcomes is unclear. Objectives: We sought to assess the impact of receiving screening scores for clinical and patient outcomes using the COPD Assessment in Primary Care To Identify Undiagnosed Respiratory Disease and Exacerbation Risk (CAPTURE) tool. Methods: Thi…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.